Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study

BackgroundLittle is known regarding disease-specific mortality of differentiated thyroid cancer (DTC) patients and its risk factors in Korea.MethodsWe retrospectively reviewed a large multi-center cohort of thyroid cancer from six Korean hospitals and included 8,058 DTC patients who underwent initia...

Full description

Bibliographic Details
Main Authors: Min Ji Jeon, Won Gu Kim, Tae Hyuk Kim, Hee Kyung Kim, Bo Hyun Kim, Hyon-Seung Yi, Eun Sook Kim, Hosu Kim, Young Nam Kim, Eun Heui Kim, Tae Yong Kim, Sun Wook Kim, Ho-Cheol Kang, Jae Hoon Chung, Young Kee Shong, Won Bae Kim
Format: Article
Language:English
Published: Academya Publishing Co. 2017-11-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-434.pdf
id doaj-11c36f3779654a8cbedd260b0d6683fb
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Min Ji Jeon
Won Gu Kim
Tae Hyuk Kim
Hee Kyung Kim
Bo Hyun Kim
Hyon-Seung Yi
Eun Sook Kim
Hosu Kim
Young Nam Kim
Eun Heui Kim
Tae Yong Kim
Sun Wook Kim
Ho-Cheol Kang
Jae Hoon Chung
Young Kee Shong
Won Bae Kim
spellingShingle Min Ji Jeon
Won Gu Kim
Tae Hyuk Kim
Hee Kyung Kim
Bo Hyun Kim
Hyon-Seung Yi
Eun Sook Kim
Hosu Kim
Young Nam Kim
Eun Heui Kim
Tae Yong Kim
Sun Wook Kim
Ho-Cheol Kang
Jae Hoon Chung
Young Kee Shong
Won Bae Kim
Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
Endocrinology and Metabolism
Mortality
Risk factors
Thyroid neoplasms
author_facet Min Ji Jeon
Won Gu Kim
Tae Hyuk Kim
Hee Kyung Kim
Bo Hyun Kim
Hyon-Seung Yi
Eun Sook Kim
Hosu Kim
Young Nam Kim
Eun Heui Kim
Tae Yong Kim
Sun Wook Kim
Ho-Cheol Kang
Jae Hoon Chung
Young Kee Shong
Won Bae Kim
author_sort Min Ji Jeon
title Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
title_short Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
title_full Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
title_fullStr Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
title_full_unstemmed Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
title_sort disease-specific mortality of differentiated thyroid cancer patients in korea: a multicenter cohort study
publisher Academya Publishing Co.
series Endocrinology and Metabolism
issn 2093-596X
2093-5978
publishDate 2017-11-01
description BackgroundLittle is known regarding disease-specific mortality of differentiated thyroid cancer (DTC) patients and its risk factors in Korea.MethodsWe retrospectively reviewed a large multi-center cohort of thyroid cancer from six Korean hospitals and included 8,058 DTC patients who underwent initial surgery between 1996 and 2005.ResultsMean age of patients at diagnosis was 46.2±12.3 years; 87% were females. Most patients had papillary thyroid cancer (PTC; 97%) and underwent total thyroidectomy (85%). Mean size of the primary tumor was 1.6±1.0 cm. Approximately 40% of patients had cervical lymph node (LN) metastases and 1.3% had synchronous distant metastases. During 11.3 years of follow-up, 150 disease-specific mortalities (1.9%) occurred; the 10-year disease-specific survival (DSS) rate was 98%. According to the year of diagnosis, the number of disease-specific mortality was not different. However, the rate of disease-specific mortality decreased during the study period (from 7.7% to 0.7%). Older age (≥45 years) at diagnosis, male, follicular thyroid cancer (FTC) versus PTC, larger tumor size (>2 cm), presence of extrathyroidal extension (ETE), lateral cervical LN metastasis, distant metastasis and tumor node metastasis (TNM) stage were independent risk factors of disease-specific mortality of DTC patients.ConclusionThe rate of disease-specific mortality of Korean DTC patients was 1.9%; the 10-year DSS rate was 98% during 1996 to 2005. Older age at diagnosis, male, FTC, larger tumor size, presence of ETE, lateral cervical LN metastasis, distant metastasis, and TNM stages were significant risk factors of disease-specific mortality of Korean DTC patients.
topic Mortality
Risk factors
Thyroid neoplasms
url https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-434.pdf
work_keys_str_mv AT minjijeon diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT wongukim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT taehyukkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT heekyungkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT bohyunkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT hyonseungyi diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT eunsookkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT hosukim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT youngnamkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT eunheuikim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT taeyongkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT sunwookkim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT hocheolkang diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT jaehoonchung diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT youngkeeshong diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
AT wonbaekim diseasespecificmortalityofdifferentiatedthyroidcancerpatientsinkoreaamulticentercohortstudy
_version_ 1725039012636262400
spelling doaj-11c36f3779654a8cbedd260b0d6683fb2020-11-25T01:41:54ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782017-11-0132443444110.3803/EnM.2017.32.4.434Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort StudyMin Ji Jeon0Won Gu Kim1Tae Hyuk Kim2Hee Kyung Kim3Bo Hyun Kim4Hyon-Seung Yi5Eun Sook Kim6Hosu Kim7Young Nam Kim8Eun Heui Kim9Tae Yong Kim10Sun Wook Kim11Ho-Cheol Kang12Jae Hoon Chung13Young Kee Shong14Won Bae Kim15Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.BackgroundLittle is known regarding disease-specific mortality of differentiated thyroid cancer (DTC) patients and its risk factors in Korea.MethodsWe retrospectively reviewed a large multi-center cohort of thyroid cancer from six Korean hospitals and included 8,058 DTC patients who underwent initial surgery between 1996 and 2005.ResultsMean age of patients at diagnosis was 46.2±12.3 years; 87% were females. Most patients had papillary thyroid cancer (PTC; 97%) and underwent total thyroidectomy (85%). Mean size of the primary tumor was 1.6±1.0 cm. Approximately 40% of patients had cervical lymph node (LN) metastases and 1.3% had synchronous distant metastases. During 11.3 years of follow-up, 150 disease-specific mortalities (1.9%) occurred; the 10-year disease-specific survival (DSS) rate was 98%. According to the year of diagnosis, the number of disease-specific mortality was not different. However, the rate of disease-specific mortality decreased during the study period (from 7.7% to 0.7%). Older age (≥45 years) at diagnosis, male, follicular thyroid cancer (FTC) versus PTC, larger tumor size (>2 cm), presence of extrathyroidal extension (ETE), lateral cervical LN metastasis, distant metastasis and tumor node metastasis (TNM) stage were independent risk factors of disease-specific mortality of DTC patients.ConclusionThe rate of disease-specific mortality of Korean DTC patients was 1.9%; the 10-year DSS rate was 98% during 1996 to 2005. Older age at diagnosis, male, FTC, larger tumor size, presence of ETE, lateral cervical LN metastasis, distant metastasis, and TNM stages were significant risk factors of disease-specific mortality of Korean DTC patients.https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-434.pdfMortalityRisk factorsThyroid neoplasms